REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMorgan Sindall Group Regulatory News (MGNS)

Share Price Information for Morgan Sindall Group (MGNS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,425.00
Bid: 2,390.00
Ask: 2,405.00
Change: 0.00 (0.00%)
Spread: 15.00 (0.628%)
Open: 2,435.00
High: 2,435.00
Low: 2,390.00
Prev. Close: 2,425.00
MGNS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AGM Voting Update

4 Sep 2023 12:51

RNS Number : 3096L
Morgan Sindall Group PLC
04 September 2023
 

Morgan Sindall Group plc

Legal Entity Identifier (LEI) number: 2138008339ULDGZRB345

 

4 September 2023

Morgan Sindall Group plc ("the Company")

 

Update on response to 2023 AGM voting outcome

 

At our Annual General Meeting ('AGM') held on 4 May 2023, resolution 3 (Approval of the Directors' Remuneration Policy) was supported by a large majority of shareholders but received less than 80% support overall.

 

In advance of the 2023 AGM, the Remuneration Committee (the 'Committee') undertook a detailed engagement with the Company's largest shareholders in relation to the remuneration proposals, and had amended the final Remuneration Policy design in response to feedback received. Following the 2023 AGM, the Committee reached out to the Company's largest shareholders to continue the dialogue and listen to their views - and in particular to understand why those who either abstained or voted against the Directors' Remuneration Policy ('the 'Policy') had done so.

 

The Committee received responses from eight investors, the majority of whom reconfirmed support for the Policy and the management team. 

 

One shareholder raised the annual bonus deferral requirement and 2nd-year phasing down of the post-employment shareholding requirement as their reason for not supporting the resolution. In both cases the Committee is comfortable that its current approach supports appropriate alignment of executive and shareholder interests. In respect of the annual bonus deferral requirement, the Committee also considers this requirement appropriate given the current shareholdings of incumbent Executive Directors. However, the Committee will reconsider both of these Policy design features as part of the next Policy review.

 

The Committee also received feedback from two shareholders that their voting had reflected the 'against' recommendation from one of the major proxy voting agencies, which itself was primarily a result of the simultaneous increases to the Policy headroom available under the annual bonus and LTIP schemes. On this matter, the Committee maintains its view that the Policy should be sufficiently flexible to last for a full triennial review period rather than needing to revert to shareholders to seek incremental changes, and reiterates its commitment to write out to major shareholders in advance of using the increased maximum opportunities under either of the variable incentives.

 

Another shareholder requested that the Committee provide a full explanation in its Remuneration Report of the rationale for the adoption of any increase to the executive directors' incentive opportunities in future years, particularly in relation to the achievement of key strategic objectives, and this feedback is consistent with the current thinking of the Committee.

 

The Committee continues to be grateful for the feedback received and the two-way engagement with major shareholders. Given overall majority support was obtained for the Policy resolution, it is not proposed to make any further changes to the approach to remuneration that was set out in the 2022 Annual Report. The Company will, however, continue to keep the Policy under review over the coming years and welcomes ongoing dialogue with shareholders and proxy advisers.

 

 

Enquiries:

Clare Sheridan, Company Secretary +44 (0) 20 7307 9200

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFZLFBXKLEBBF
Date   Source Headline
9th Jul 20197:00 amRNSNotice of Results
1st Jul 201910:20 amRNSTotal Voting Rights
24th Jun 20194:05 pmRNSHolding(s) in Company
31st May 20193:13 pmRNSHolding(s) in Company
31st May 20199:33 amRNSTotal Voting Rights
22nd May 20199:23 amRNSDirector Declaration
16th May 20198:30 amRNSAdditional Listing
9th May 201910:11 amRNSAwarded £1.6bn Sellafield contract
8th May 201912:21 pmRNSResult of AGM
8th May 20197:00 amRNSAGM Trading Update
1st May 201912:26 pmRNSTotal Voting Rights
23rd Apr 201912:05 pmRNSBlock listing Interim Review
1st Apr 201910:03 amRNSTotal Voting Rights
22nd Mar 20197:00 amRNSMorgan Sindall Group announces £1bn joint venture
21st Mar 201911:38 amRNSAnnual Financial Report
14th Mar 20193:36 pmRNSAdditional Listing - Amendment
14th Mar 20198:00 amRNSAdditional Listing
5th Mar 20194:03 pmRNSHolding(s) in Company
4th Mar 20193:19 pmRNSDirector/PDMR Shareholding
4th Mar 20193:13 pmRNSDirector/PDMR Shareholding
4th Mar 20193:10 pmRNSDirector/PDMR Shareholding
1st Mar 20191:58 pmRNSTotal Voting Rights
21st Feb 20197:00 amRNSFinal Results
1st Feb 201910:28 amRNSTotal Voting Rights
10th Jan 20193:37 pmRNSHolding(s) in Company
9th Jan 20197:00 amRNSNotice of Results
3rd Jan 20192:04 pmRNSTotal Voting Rights
19th Dec 201810:54 amRNSDirector Declaration
3rd Dec 20184:37 pmRNSTotal Voting Rights
20th Nov 20187:00 amRNSSenior Management Forum
16th Nov 20182:53 pmRNSDirector/PDMR Shareholding
1st Nov 20187:00 amRNSTrading Update
29th Oct 201811:30 amRNSNotice of Trading Update
22nd Oct 20189:01 amRNSBlock listing Interim Review
9th Oct 20184:08 pmRNSHolding(s) in Company
1st Oct 201810:08 amRNSTotal Voting Rights
28th Sep 20183:47 pmRNSHolding(s) in Company
27th Sep 20188:00 amRNSDirectorate Change
24th Sep 20188:18 amRNSHolding(s) in Company
4th Sep 20184:15 pmRNSHolding(s) in Company
3rd Sep 201812:02 pmRNSHolding(s) in Company
3rd Sep 20189:25 amRNSTotal Voting Rights
14th Aug 20187:00 amRNSDirectorate Change
8th Aug 20187:00 amRNSHalf-year Report
3rd Aug 20183:10 pmRNSHolding(s) in Company
1st Aug 20189:47 amRNSTotal Voting Rights
11th Jul 20183:16 pmRNSHolding(s) in Company
11th Jul 20187:00 amRNSNotice of Results
2nd Jul 201811:31 amRNSTotal Voting Rights
4th Jun 20184:34 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.